Analyses the global supply chains for QS-21 and MPL, two vaccine adjuvants used in several vaccines, including the potential TB vaccine M72/AS01E. The report examines supply, demand, manufacturers, raw-material sourcing, market concentration, sustainability and potential supply bottlenecks.